November 21, 2016 U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the - Tampa - Document - PDFSEARCH.IO

First Page	Meta Content
	November 21, 2016 U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in the Add to Reading List Document Date: 2016-11-21 07:45:02 Open Document File Size: 40,45 KB Share Result on Facebook

November 21, 2016 U.S. FDA Grants Fast Track Designation for the Development of Oragenics’ AG013 for Oral Mucositis TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics (NYSE:MKT - OGEN.BC), a leader in theAdd to Reading List